openPR Logo
Press release

Research Report Prospects the Duodenoscope Market

11-29-2017 12:42 PM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights

Duodenoscope is a side viewing endoscope primarily designed for Endoscopic Retrograde Cholangiopancreatography (ERCP) to diagnose diseases associated with pancreas and bile ducts with the help of fluoroscopic imaging procedure. Duodenoscopes are flexible, light weighted tubes that are relieved through the mouth, throat, and stomach till the duodenum portion. Duodenoscopes are being used in more than 500,000 gastrointestinal procedures in the U.S each year as a minimally invasive way than traditional surgery to drain fluids from biliary and pancreatic ducts which are blocked by cancerous tumors, gallstones or other gastrointestinal conditions.

The Duodenoscope is a more complex device than other endoscopes and more tough to clean and disinfect. While these devices play an essential role in the treatment of patients, there is an evidence that some patients have been transmitted with hospital born and other infectious agents, including antibiotic drug-resistant infections. In 2013, the Centers for Disease Control and Prevention (CDC) alerted the FDA regarding possible association of multidrug resistant bacterial infections and duodenoscopes. Even before FDA was reported of the infections by the CDC, FDA was working to reinforce cleaning and disinfection protocols of complex duodenoscopes devices to maximize patient benefit and reduce safety risks. Recently American Society for Gastrointestinal Endoscopy (ASGE) brought together experts in epidemiology, infection control and endoscopy, FDA and CDC representatives, hospitals that practiced epidemics, and device manufacturers. The purposes of these organizations to confirm current FDA and industry guidelines for cleaning duodenoscopes and identify gaps in knowledge and issues to address going onward.

Read Report Overview@ https://www.futuremarketinsights.com/reports/duodenoscope-market

Based on product type, global duodenoscopes market is classified as follows:

Flexible Video Dueodenoscopes

Flexible Non- Video Dueodenoscopes

Based on End User type, global duodenoscopes market is classified as follows:

Hospitals

Pediatric Centers

Clinics

Ambulatory Surgical Centers

Currently, owing to extremely spread of infection of Carbapenem-Resistant Enterobacteriaceae (CRE) bacteria, through duodenoscopes, the procedure is probably not performing in an outpatient facility such as clinics and ambulatory surgical centers.

Increasing incidences of pancreatic, bile duct cancer tumors and various gastrointestinal conditions are the major origins contributing to the growth of the global duodenoscopes market. In addition, increasing FDA activities and CDC and manufactures collaboration is in identifying the causes and risk factors for transmission of infectious agents with duodenoscopes and developing new solutions to minimize patient exposure is another major driver, fueling the global duodenoscopes market growth over the forecast period. However, increasing FDA recalls for duodenoscopes owing to challenging cleaning and high-level disinfection procedures associated with complex designed duodenoscopes and rising multidrug-resistant bacterial infections caused by Carbapenem-Resistant Enterobacteriaceae (CRE) such as Klebsiella species and Escherichia coli are major factors are expected to hamper the growth of global duodenoscopes market over the forecast period.

Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1667

Geographically global duodenoscopes market has been segmented into North America, Latin America, Europe, Asia-Pacific & Japan, Middle East Africa regions. North America region has been estimated as most dominant region in the global duodenoscopes market owing highly developed healthcare infrastructure and high rates of awareness regarding duodenoscopes and its associated infections among physicians. Asia-Pacific & Japan is a lucrative market for global duodenoscopes. Countries in the Asia Pacific regions include, greater China and India together account for largest population pool in the world and thereby have large pool of geriatric population are expected to fuel the growth of duodenoscopes market in the region.

Some of the key companies contributing to global duodenoscopes market are Fujifilm Holdings Corporation, KARL STORZ GmbH & Co. KG., Olympus Corporation, PENTAX Medical Company, and Hoya Corporation.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website :www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Report Prospects the Duodenoscope Market here

News-ID: 837554 • Views:

More Releases from Future Market Insights

Anatomic Pathology Track and Trace Solution Market Forecast (2024-2034): 11.5% CAGR
Anatomic Pathology Track and Trace Solution Market Forecast (2024-2034): 11.5% C …
The anatomic pathology track and trace solution market is projected to reach a valuation of USD 2.4 billion by 2034, up from an estimated USD 807.2 million in 2024. This growth reflects a strong compound annual growth rate (CAGR) of 11.5% over the forecast period. The global healthcare landscape continues to undergo profound transformation, driven by technological innovation, evolving patient expectations, and a persistent demand for accuracy and efficiency. Within this
Electronic Medical Record Market Set to Grow at 6.2% CAGR Through 2034
Electronic Medical Record Market Set to Grow at 6.2% CAGR Through 2034
Future Market Insights' updated report on the electronic medical record (EMR) ecosystem highlights a range of emerging opportunities and growth pathways expected to shape the industry over the next ten years. The analysis indicates that the EMR market is firmly positioned in 2024, driven by increasing digitalization across healthcare systems. As end-users demand more accessible and efficient solutions, EMR providers are prioritizing intuitive interfaces and streamlined functionalities to meet those
Cheese Analogue Market to Reach USD 4.46 Billion by 2035 Amid Rising Demand for Plant-Based Alternatives
Cheese Analogue Market to Reach USD 4.46 Billion by 2035 Amid Rising Demand for …
The cheese analogue market is projected to reach USD 2,400 million in 2025 and is anticipated to surge to USD 4,460 million by 2035, expanding at a CAGR of 6% over the forecast period. This growth is largely driven by increasing consumer demand for vegan, lactose-free, and plant-based food options, as well as rising awareness of cholesterol-free alternatives among health-conscious populations. The rapid development of the global food processing industry
Ginseng Extracts Market to Hit USD 18.9 Billion by 2035, Fueled by Rising Demand for Herbal and Functional Ingredients
Ginseng Extracts Market to Hit USD 18.9 Billion by 2035, Fueled by Rising Demand …
The global Ginseng Extracts Market is poised for significant expansion in the coming decade. In 2025, the market is expected to reach a value of USD 12,304.4 million. Driven by growing consumer awareness and adoption of herbal remedies and natural health supplements, the market is projected to expand at a CAGR of 4.4% from 2025 to 2035, ultimately reaching USD 18,906.4 million by the end of the forecast period. Ginseng, a

All 5 Releases


More Releases for FDA

Dengue Pipeline Drugs, FDA Approvals, and Companies 2024
DelveInsight's, "Dengue- Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Dengue Research. Learn more about our innovative
DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes
Fully Differential Amplifier (FDA) Market Shows Strong Expansion |
The most recent report published by Market Research Inc. indicates that the Fully Differential Amplifier (FDA) Market is likely to accelerate significantly in the next few years. Specialists have studied market drivers, restraints, risks and prospects in the global market. The Fully Differential Amplifier (FDA) Market report shows the likely direction of the market in the coming years along with its assessments. By analyzing the competitive landscape, the authors of
St. Louis-based Air Cleaner Earns FDA Clearance
Micron Pure develops tech powering CerroZone, a Berkshire Hathaway and Marmon Holdings Company. Chesterfield, Missouri, July 21, 2022. Micron Pure is pleased to announce that its patented ozone technology recently received Federal Drug Administration (FDA) 510(k) Class II clearance for the CerroZone Mobile device as a recirculating air cleaner for eliminating airborne Viruses and Bacteria. Micron Pure has licensed the technology to Marmon Holdings, a Berkshire Hathaway Company, who will be selling Air
FDA SETS A NEW GOAL FOR SODIUM REDUCTION
The U.S. Food and Drug Administration released voluntary short-term (2,5 year) sodium reduction guidelines for the food industry on October 14, 2021. The new guidelines include sodium reduction targets for 163 categories of commercially processed, packaged, and restaurant foods. The FDA aims to address the excessive intake of sodium among Americans and promote better public health. The new sodium reduction guidelines will affect food manufacturers, chain restaurants, and foodservice operators. According
Austrianova files Drug Master File with FDA
S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA). This DMF provides all confidential and detailed information covering the production of Cell-in-a-Box® encapsulated cell products based on encapsulated HEK293 cells and derivatives. This includes CypCaps™, the encapsulated cell product that its’ partner and client PharmaCyte Biotech Inc., is about to use in